Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine for Asthma
NCT03883984Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jun 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in asthma comparing Cysteamine with Placebo Oral Tablet (2 arms). Primary endpoint: Asthma Symptom Severity Score at 12 weeks. Started Jun 2019; status: completed.
02
Drugs
cysteamine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03883984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883984.